Scholars@Duke publication: ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients.

ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients.

Publication , Journal Article

Conlon, PJ; Albers, F; Butterly, D; Schwab, SJ

Published in: Nephrol Dial Transplant

1994

Nephrol Dial Transplant

0931-0509

1994

1358

England

APA

Chicago

ICMJE

MLA

NLM

Conlon, P. J., Albers, F., Butterly, D., & Schwab, S. J. (1994). ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients. Nephrol Dial Transplant, 9(9), 1358.

Conlon, P. J., F. Albers, D. Butterly, and S. J. Schwab. “ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients.” Nephrol Dial Transplant 9, no. 9 (1994): 1358.

Conlon PJ, Albers F, Butterly D, Schwab SJ. ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients. Nephrol Dial Transplant. 1994;9(9):1358.

Conlon, P. J., et al. “ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients.” Nephrol Dial Transplant, vol. 9, no. 9, 1994, p. 1358.

Conlon PJ, Albers F, Butterly D, Schwab SJ. ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients. Nephrol Dial Transplant. 1994;9(9):1358.

Nephrol Dial Transplant

0931-0509

1994

1358

England